+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483528
  • Report
  • November 2021
  • Region: Global
  • 145 Pages
  • IMARC Group

FEATURED COMPANIES

  • Abbvie Inc.
  • Amgen Inc.
  • Celgene
  • Gilead Sciences Inc.
  • Novartis AG
  • Pfizer Inc.
The global acute myeloid leukemia therapeutics market grew at a CAGR of around 7% during 2015-2020. Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It primarily impacts the bone marrow and white blood cells (WBCs) and is characterized by the discoloration of skin, breathlessness, fatigue, high body temperatures, weight loss, bleeding gums and nosebleeds. Some of the commonly used AML therapies include chemo-, immuno-, targeted- and hormonal therapies and surgical procedures. These therapeutics are usually combined with stem cell transplants to increase the efficacy, minimize complications and strengthen the immune system of the body.

The increasing prevalence of leukemia across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such disorders, is also driving the market growth. AML is primarily caused by genetic mutations in the body that impacts the levels of blood cell production. In line with this, the widespread adoption of combination and targeted therapies and increasing awareness regarding the available alternatives for cancer treatment are also favoring the market growth. Additionally, the advent of improved immunotoxins, alkylating agents, monoclonal antibodies and multidrug-resistant modulators is another major growth-inducing factor. These therapeutics offer prolonged results, higher efficacy, early and accurate identification of leukemia cells and reduced chances of cancer relapse. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with significant improvements in the existing healthcare infrastructure, are anticipated to drive the market further. Looking forward, the publisher expects the global acute myeloid leukemia therapeutics market to exhibit moderate growth during the next five years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global acute myeloid leukemia therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, treatment type, drug type and route of administration.

Breakup by Treatment Type:

  • Cytarabine
  • Anthracycline Drugs
  • Alkylating Agents
  • Anti-Metabolites
  • Tyrosine Kinase Inhibitors
  • Others

Breakup by Drug Type:

  • Small Molecule Drugs
  • Biopharmaceuticals

Breakup by Route of Administration:

  • Oral
  • Injectables

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbvie Inc., Amgen Inc. , Bristol-Myers Squibb Company, Celgene, Roche Holding AG, Gilead Sciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report:

  • How has the global acute myeloid leukemia therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global acute myeloid leukemia therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global acute myeloid leukemia therapeutics market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc.
  • Amgen Inc.
  • Celgene
  • Gilead Sciences Inc.
  • Novartis AG
  • Pfizer Inc.

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Acute Myeloid Leukemia Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment Type
6.1 Cytarabine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anthracycline Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alkylating Agents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Anti-Metabolites
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tyrosine Kinase Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Small Molecule Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biopharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Celgene
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Roche Holding AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Gilead Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Acute Myeloid Leukemia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Treatment Type (in %), 2020
Figure 5: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Region (in %), 2020
Figure 8: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Acute Myeloid Leukemia Therapeutics (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Acute Myeloid Leukemia Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: North America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: North America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: North America: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2020
Figure 31: United States: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: United States: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Canada: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Canada: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2020
Figure 38: China: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: China: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Japan: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Japan: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: India: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: India: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: South Korea: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: South Korea: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Australia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Australia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Indonesia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Indonesia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Europe: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Europe: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2020
Figure 55: Germany: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Germany: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: France: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: France: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: United Kingdom: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: United Kingdom: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Italy: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Italy: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Spain: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Spain: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Russia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Russia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Latin America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Latin America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Latin America: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2020
Figure 72: Brazil: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2020
Figure 81: Global: Acute Myeloid Leukemia Therapeutics Industry: SWOT Analysis
Figure 82: Global: Acute Myeloid Leukemia Therapeutics Industry: Value Chain Analysis
Figure 83: Global: Acute Myeloid Leukemia Therapeutics Industry: Porter's Five Forces Analysi
List of Tables
Table 1: Global: Acute Myeloid Leukemia Therapeutics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 5: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Acute Myeloid Leukemia Therapeutics Market: Competitive Structure
Table 7: Global: Acute Myeloid Leukemia Therapeutics Market: Key Players
Note: Product cover images may vary from those shown
  • Abbvie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Celgene
  • Roche Holding AG
  • Gilead Sciences Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited.
Note: Product cover images may vary from those shown

Loading
LOADING...